Amendment No. 1 to Promissory Note between Chromocell Therapeutics Corporation and Todd Davis

Contract Categories: Business Finance › Note Agreements
Summary

Chromocell Therapeutics Corporation and lender Todd Davis have agreed to amend their original promissory note dated December 6, 2022. The amendment extends the loan's maturity date to February 29, 2024. In exchange for this extension, Chromocell will pay Todd Davis an additional $100. All other terms of the original note remain unchanged and in effect.

Read More Arrow
EX-4.29 10 g083881_ex4-29.htm EXHIBIT 4.29

EXHIBIT 4.29

CHROMOCELL THERAPEUTICS CORPORATION

Amendment No. 1 to Promissory Note

Face Amount: $175,000.00  December 28, 2023
Purchase Price: $100,000.00  New York, NY

 

Chromocell Therapeutics Corporation, a Delaware corporation (the “Borrower”), and Todd Davis, his successors or assigns (the “Lender”), pursuant to that certain Promissory Note, dated December 6, 2022 (the “Note”), do hereby agree to amend the Note to extend the Maturity Date (as defined in the Note) to February 29, 2024.

In consideration thereof, the Company agrees to pay to Lender the amount of One Hundred Dollars ($100).

 

Except as specifically set forth herein, Borrower and Lender hereby confirm that the terms of the Note remain unmodified and in full force and effect.

  BORROWER:
     
  Chromocell Therapeutics Corporation
     
     
  By: /s/ Francis Knuettel II
    Name: Francis Knuettel II
    Title: Chief Financial Officer
     
     
  LENDER:
     
  By: /s/ Todd Davis
    Todd Davis